Marc Rodger profile picture

Contact Information

Marc Rodger
613 737 8899 ext 74641
mrodger@ohri.ca

ORCID logo https://orcid.org/0000-0001-8166-3487

News

Milestone study will help doctors treat life threatening blood clots
October 22, 2019 - Faizan Khan’s research will influence how doctors around the world treat venous thrombosis, the third-deadliest cardiovascular disease. This is a remarkable achievement for a PhD candidate in the early stages of his career.
Study establishes long-term risks and consequences of leg vein clot recurrence
July 31, 2019 - Over 750,000 Canadians will have an unexplained vein blood clot in their lifetime, known as venous thrombosis. A collaborative study led by Dr. Marc Rodger and Faizan Khan now provides the best data yet on the long-term risks and consequences of ...
The Ottawa Hospital awarded 13 grants worth $11.2 million from Canadian Institutes of Health Research
July 26, 2019 - Researchers at The Ottawa Hospital have been awarded 13 grants worth a total of $11.2 million from the Canadian Institutes of Health Research (CIHR). The new projects focus on areas such as cancer immunotherapy, hepatitis C infection, blood ...
Researchers to advance science and improve health with new CIHR funding
February 14, 2019 - Researchers at The Ottawa Hospital, affiliated with the University of Ottawa, are playing a lead role in nine new projects funded by the Canadian Institutes of Health Research (CIHR). These projects will advance science and improve health in ...
Drug dramatically reduces risk of dangerous blood clots in cancer patients
December 4, 2018 - A Canadian clinical trial published in the New England Journal of Medicine provides the first approach for safely preventing blood clots (or venous thromboembolism) in people with cancer. About half of people newly diagnosed with a solid cancer ...
Top Research Papers from The Ottawa Hospital 2015-2017
June 7, 2018 - Did you know that researchers at The Ottawa Hospital publish an average of four new scientific papers every single day? Our research is advancing science and improving health on a massive scale – both at home and around the world. The list below ...
Aspirin as good as blood thinner for preventing blood clots after hip and knee replacement surgery
April 6, 2018 - Drs. Paul Kim, Wade Gofton, Phil Wells, Marc Rodger, Marc Carrier and Doug Coyle co-authored a study in the New England Journal of Medicine that found aspirin to be just as good as the blood thinner rivaroxaban for preventing blood clots after a ...
Midwife’s question inspires study on best blood clot treatment
July 11, 2017 - Midwife Elizabeth Fraser wanted to know how to reduce her risk of blood clots during pregnancy, and inspired a study that could help others with her rare condition. Elizabeth Fraser jokes that she had one of the world’s most-planned pregnancies.
The Ottawa Hospital awarded 18 research grants from the Canadian Institutes of Health Research, worth $10.7 million
May 19, 2017 - Eighteen research groups at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded nearly $11 million in the most recent project grant competition from the Canadian Institutes of Health Research (CIHR). This represents a suc
Tattoo artist grateful to be off blood thinners thanks to made-in-Ottawa rule
April 26, 2017 - Ottawa resident Sarah Rogers would have been taking blood thinners for life, if not for a rule that showed she was at low risk of having a second blood clot. Ottawa tattoo artist Sarah Rogers thought she’d pulled a muscle when her right leg star
Over 10,000 Canadian women per year can stop taking blood thinners for unexplained vein clots
April 4, 2017 - Rule identifies women who have low risk of vein blood clot recurrence A Canadian-led research group has developed and validated a rule that could let half of women with unexplained vein blood clots stop taking blood thinners for life. These find
“Invaluable” study confirms blood thinners don’t prevent recurrent pregnancy complications
October 18, 2016 - Two years ago, Dr. Marc Rodger thought he had settled the debate about the use of blood thinners in pregnant women at high risk of developing blood clots. His trial of 292 women in five countries – the largest of its kind – definitely showed that t
The Ottawa Hospital awarded $27 million from Canadian Institutes of Health Research for 13 research projects
August 19, 2016 - Thirteen teams at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded more than $27 million in the latest round of research grants from the Canadian Institutes of Health Research (CIHR). Four of The Ottawa Hospital’
Cardiovascular researchers get $1.2M boost from Heart and Stroke Foundation
May 4, 2016 - Five scientists from the Ottawa Hospital Research Institute were successful in the Heart and Stroke Foundation’s recent grant-in-aid grant competition, representing a success rate of 50% compared to the national average of 20%. The new funding wi
National research network to improve outcomes for venous thromboembolism patients established at Lady Davis Institute and The Ottawa Hospital --WORLD THROMBOSIS DAY – OCTOBER 13, 2015
October 5, 2015 - In recognition of the seriousness and prevalence of venous thromboembolism (VTE), the Canadian Institutes of Health Research (CIHR), the Fonds de recherche Québec – Santé (FRQS), and a consortium of public and private funders, including the Lady Davi
Blood thinner study in pregnant women receives national award
December 17, 2014 - Dr. Marc Rodger recently received the Canadian Hematology Society’s clinical paper of the year award for his international clinical trial of blood thinners in pregnant women, published in The Lancet. The trial showed that daily blood thinner injectio
Common blood thinner for pregnant women proven ineffective: Lancet study
July 24, 2014 - OTTAWA – It's a daily injection to the belly for pregnant women at risk of developing blood clots and it's ineffective, according to a clinical trial led by researchers at The Ottawa Hospital and published today by the prestigious medical journal The